Solid lipid nanoparticles for parenteral drug delivery
Top Cited Papers
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 56 (9), 1257-1272
- https://doi.org/10.1016/j.addr.2003.12.002
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug DiminazenediaceturateJournal of Drug Targeting, 2002
- Encapsulation of retinoids in solid lipid nanoparticles (SLN)Journal of Microencapsulation, 2001
- Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsPharmacological Research, 2000
- Solid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: a 1H-NMR studyInternational Journal of Pharmaceutics, 2000
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInternational Journal of Pharmaceutics, 1998
- Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitateInternational Journal of Pharmaceutics, 1997
- Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJournal of Controlled Release, 1994
- Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscopeJournal of Molecular Biology, 1964